Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: BIOAEGIS THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2021-06-11 to 2022-07-29
Current total value of award: $749000
Description: EO14042 DEVELOP A SAFE AND EFFECTIVE THERAPEUTIC TO MITIGATE SEVERE OUTCOMES, INCLUDING BUT NOT LIMITED TO MORTALITY, IN PATIENTS WITH SEVERE INFECTION OR SEPSIS OF ANY ETIOLOGY.